» Articles » PMID: 7734458

A Preliminary Investigation of Outcome Following Gradual or Rapid Buprenorphine Detoxification

Overview
Journal J Addict Dis
Publisher Informa Healthcare
Date 1994 Jan 1
PMID 7734458
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Eight opioid-dependent individuals were maintained on daily sublingual buprenorphine (8 mg) for 28 days and assigned randomly to one of two outpatient detoxification schedules under double-blind, double-dummy conditions. The two detoxification schedules were buprenorphine gradual (36 days; N = 3) or buprenorphine rapid (12 days; N = 5). Outcome variables were subject- and observer-ratings of opioid withdrawal, treatment retention and illicit-opioid use. Outcome measures were similar for the two groups during buprenorphine maintenance. Increases in subject-rated opioid withdrawal and illicit-opioid use, and a drop in treatment retention occurred during rapid detoxification. Stable subject-rated opioid withdrawal and treatment retention, and less illicit-opioid use occurred during gradual detoxification. These data suggest that gradual reduction in buprenorphine dose is likely to produce superior treatment outcomes than more rapid buprenorphine detoxification.

Citing Articles

Opioid agonist treatment for people who are dependent on pharmaceutical opioids.

Nielsen S, Tse W, Larance B Cochrane Database Syst Rev. 2022; 9:CD011117.

PMID: 36063082 PMC: 9443668. DOI: 10.1002/14651858.CD011117.pub3.


Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.

Borodovsky J, Levy S, Fishman M, Marsch L J Addict Med. 2018; 12(3):170-183.

PMID: 29432333 PMC: 5970018. DOI: 10.1097/ADM.0000000000000388.


Buprenorphine for managing opioid withdrawal.

Gowing L, Ali R, White J, Mbewe D Cochrane Database Syst Rev. 2017; 2:CD002025.

PMID: 28220474 PMC: 6464315. DOI: 10.1002/14651858.CD002025.pub5.


Characterizing opioid withdrawal during double-blind buprenorphine detoxification.

Dunn K, Saulsgiver K, Miller M, Nuzzo P, Sigmon S Drug Alcohol Depend. 2015; 151:47-55.

PMID: 25823907 PMC: 4447545. DOI: 10.1016/j.drugalcdep.2015.02.033.


Comparative trial to study the effectiveness of clonidine hydrochloride and buprenorphine-naloxone in opioid withdrawal - a hospital based study.

Hussain S, Farhat S, Rather Y, Abbas Z J Clin Diagn Res. 2015; 9(1):FC01-4.

PMID: 25738001 PMC: 4347092. DOI: 10.7860/JCDR/2015/10625.5425.